ArticleEClinicalMedicine2024

Induction sintilimab and chemotherapy followed by concurrent chemoradiotherapy for locally advanced esophageal cancer: a proof-of-concept, single-arm, multicenter, phase 2 trial.

Dashan Ai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.